1. Allogeneic Hematopoietic Cell Transplantation for Patients with Mixed Phenotype Acute Leukemia 
Reinhold Munker, Ruta Brazauskas, Hai Lin Wang, Marcos de Lima, Hanna J. Khoury, Robert Peter Gale, Richard T. Maziarz, Brenda M. Sandmaier, Daniel Weisdorf, Wael Saber 
Biology of Blood and Marrow Transplantation 
Volume 22, Issue 6, Pages (June 2016)
DOI: /j.bbmt
Copyright © 2016 The American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
Proportion of patients with the different immunophenotypes (My+B indicates patients coexpressing myeloid and B lymphoid markers according to the WHO classification; My+T, myeloid and T lymphoid markers; My+T+B, myeloid+T+B lymphoid; T+B, T+B lymphoid.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2016 The American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
Kaplan-Meier estimate of overall survival and leukemia-free survival of patients who underwent alloHCT for MPAL.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2016 The American Society for Blood and Marrow Transplantation Terms and Conditions